2017
DOI: 10.15406/ijcam.2017.09.00313
|View full text |Cite
|
Sign up to set email alerts
|

Sonodynamic and Photodynamic Therapy in Breast Cancer - A Pilot Study

Abstract: In this exploratory pilot study, we investigated the potential efficacy of a new systemic tumor therapeutic method as a supplementary or salvage treatment in advanced refractory breast cancer. Termed Sono-Photo Dynamic Therapy (SPDT), this technology utilizes full body and targeted ultrasound in conjunction with photodynamic therapy. Twelve patients with advanced breast carcinoma participated, eleven with metastases in the viscera and brain, and nine within bone. Nine patients had concurrent low dose chemother… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 12 publications
0
3
0
Order By: Relevance
“…The exploratory clinical study of PDT combined with sonodynamic therapy (SDT) against cholangiocarcinoma in which hematoporphyrin was used as the sono-photosensitizer provides a clear indication of the state of this technology in the clinical translation trajectory [117]. This is supported by the clinical pilot studies [118] and case reports [119] that are starting to appear in the literature. Nanotechnology is ubiquitous not only as a platform for the PDT and SDT agents [120,121], but also for other purposes of the innovation, such as hypoxia amelioration, disease targeting, imaging-guided therapy, and stimulus-responsive release.…”
Section: Photodynamic Therapy In Combination With Sonodynamic Therapymentioning
confidence: 99%
“…The exploratory clinical study of PDT combined with sonodynamic therapy (SDT) against cholangiocarcinoma in which hematoporphyrin was used as the sono-photosensitizer provides a clear indication of the state of this technology in the clinical translation trajectory [117]. This is supported by the clinical pilot studies [118] and case reports [119] that are starting to appear in the literature. Nanotechnology is ubiquitous not only as a platform for the PDT and SDT agents [120,121], but also for other purposes of the innovation, such as hypoxia amelioration, disease targeting, imaging-guided therapy, and stimulus-responsive release.…”
Section: Photodynamic Therapy In Combination With Sonodynamic Therapymentioning
confidence: 99%
“…15 However, there have been relatively few studies indicating that introducing oxygen-independent USactivated free radical generators into the SDT treatment platform can improve therapeutic outcomes in solid hypoxic tumors. 3 effectively with photodynamic therapy, 16,17 photothermal therapy, 14,18 chemotherapy, 19−21 and immunotherapy. 22,23 The use of metal−organic frameworks (MOFs) as delivery vehicles for different pharmacological agents has been found to be highly effective because of the robust drug-loading capacity and controlled drug relief properties of these nanomaterials.…”
Section: ■ Introductionmentioning
confidence: 99%
“…However, there have been relatively few studies indicating that introducing oxygen-independent US-activated free radical generators into the SDT treatment platform can improve therapeutic outcomes in solid hypoxic tumors . SDT approaches have also been shown to synergize effectively with photodynamic therapy, , photothermal therapy, , chemotherapy, and immunotherapy. , …”
Section: Introductionmentioning
confidence: 99%